Understanding transplantation
Whose cells are used?
The words “stem cell transplant” describe more than one treatment. Knowing whether the cells come from the patient or a donor helps explain the purpose, preparation and risks.
Your own cells: an autologous transplant
Blood-forming stem cells are collected from the patient and stored. After intensive treatment, the cells are returned through an infusion to restore blood production. There is no need to find a stem cell donor for this procedure.
This approach is used in multiple myeloma and some lymphomas, among other conditions. The treatment given before the transplant targets the disease; the returned cells help the marrow recover.
Using your own cells does not make the treatment risk-free. Infection, bleeding, organ effects and recurrence of the underlying disease remain important concerns.
Donated cells: an allogeneic transplant
Blood-forming cells come from another person or from donated umbilical cord blood. A team considers HLA tissue markers and other factors when choosing a donor. Options can include matched or partially matched relatives and unrelated registry donors.
The donated cells establish new blood formation. For certain cancers, donor immune cells can also attack cancer cells that remain after treatment. This is called a graft-versus-leukemia or graft-versus-tumor effect; it is not the goal of transplantation for noncancerous conditions.
Donor cells can also attack healthy tissues, causing graft-versus-host disease. Preventive medicines, donor selection and follow-up care help manage this risk. A close match does not remove every transplant risk.
Different paths through treatment
Preparation, time in hospital and recovery vary. Conditioning regimens differ in intensity, and some care can take place as an outpatient. Recovery involves blood-count monitoring and support while immune function rebuilds.
Cell and gene therapies are another distinction. Some modify the patient’s own cells and then return them; they are not the same as a conventional autologous or donor transplant. Eligibility and availability depend on the therapy and country.
The diagnosis is only part of the decision.
The same condition can have several treatment options. Disease features, previous treatment, health and personal preferences all matter. A useful question for the care team is: “Which kind of transplant are we discussing, and why?”
Sources and further reading
- Stem Cell and Bone Marrow Transplants for Cancer — National Cancer Institute
- Finding a blood stem cell donor — NMDP
Understanding can become action.
Some patients need a blood stem cell donor. Others receive different treatment. Wherever your interest began, you can help JBF reach more people who may be able to donate.
Explore the official registry serving where you live. It explains who can join, how registration works and what donation involves.
Find your official registryIf joining is not right for you, a gift to the Jada Bascom Foundation supports education, outreach and referrals to official registries.
Donate to JBF
